This review highlights the role of matrix metalloproteinases in left ventricular remodeling post-myocardial infarction and their potential as prognostic markers and therapeutic targets despite disappointing initial clinical trials.
No takes yet. Share an insight, caveat, or question.
MMPs merit evaluation as post-MI prognostic markers; leaves open whether selective inhibition can succeed after prior trial failures.
L Gabrielle (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: